Anti-Hepcidin-25 antibody [EPR18074]
- RabMAb
- Recombinant
- What is this?
4
(1 Review)
|
(3 Publications)
Rabbit Recombinant Monoclonal Hepcidin antibody. Suitable for WB and reacts with Recombinant fragment - Human, Rat, Human samples. Cited in 3 publications.
View Alternative Names
HEPC, LEAP1, UNQ487/PRO1003, HAMP, Hepcidin, Liver-expressed antimicrobial peptide 1, Putative liver tumor regressor, LEAP-1, PLTR
- WB
Supplier Data
Western blot - Anti-Hepcidin-25 antibody [EPR18074] (AB187778)
Blocking buffer : 5% NFDM/TBST.
Dilution buffer : 1% NFDM/TBST.
All lanes:
Western blot - Anti-Hepcidin-25 antibody [EPR18074] (ab187778) at 1/1000 dilution
Lane 1:
Human plasma at 20 µg
Lane 2:
Human serum at 20 µg
Lane 3:
Human liver lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (HRP), preadsorbed at 1/50000 dilution
Predicted band size: 9 kDa
Observed band size: 3 kDa
false
- WB
Supplier Data
Western blot - Anti-Hepcidin-25 antibody [EPR18074] (AB187778)
Blocking/Dilution buffer : 5% NFDM/TBST.
In house recombinant Human Hepcidin is a His-tagged fragment protein (aa25-84).
All lanes:
Western blot - Anti-Hepcidin-25 antibody [EPR18074] (ab187778) at 1/5000 dilution
All lanes:
Human Hepcidin fragment protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 9 kDa
Observed band size: 17 kDa
false
Exposure time: 1s
- WB
Lab
Western blot - Anti-Hepcidin-25 antibody [EPR18074] (AB187778)
Blocking buffer : 5% NFDM/TBST. Dilution buffer : 1% NFDM/TBST
All lanes:
Western blot - Anti-Hepcidin-25 antibody [EPR18074] (ab187778) at 1/1000 dilution
Lane 1:
Serum from rat treated with LPS at 30 µg
Lane 2:
Serum from rat treated with LPS at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (HRP), preadsorbed at 1/50000 dilution
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-Hepcidin-25 antibody [EPR18074] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Hepcidin serves as the master regulator of iron metabolism. Unlike many peptides it does not form part of a larger protein complex. Its activity ensures adequate iron levels for erythropoiesis while preventing toxic iron overload. It affects not only the liver but also distant tissues like the bone marrow and spleen. Hepcidin inhibits iron absorption in the intestine and controls iron release from macrophages and hepatic stores maintaining systemic iron concentration within a narrow range.
Pathways
Hepcidin operates within the complex network of iron metabolism and erythropoiesis pathways. It is particularly important in the liver hepcidin signaling pathway and the systemic iron regulation pathway. Hepcidin interacts closely with proteins like ferroportin its receptor and target as well as other iron transporters which ensures efficient iron allocation in the body. It also connects to other regulatory molecules like transferrin receptor and ferritin key players in iron transport and storage.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
International immunopharmacology 69:337-346 PubMed30776642
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 16:1963-1967 PubMed30186425
2018
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Molecular basis of 1863:1568-1574 PubMed28254494
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com